Home · Open Lab · Lot RGX-26-RGNX-1056
RGX-26-RGNX-1056Current
GHK-CU · 100 MG · Dermal Research · COA NS-2026-05057

Release test results

99.568%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 100.4 mg
Related impurities (total)0.432%
Endotoxin<1.0 EU/mg
HPLC retention time4.63 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundGHK-CU
Presentation100 MG
Lot numberRGX-26-RGNX-1056
COA numberNS-2026-05057
Test date06 Sep 2026
Release date09 Sep 2026
Independent labNordicstar Labs
StatusCurrent

GHK-CU — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-RGNX-105550 MGSep 8, 202699.606%Current
RGX-26-RGNX-1056 this lot100 MGSep 6, 202699.568%Current
RGX-26-RGNX-74550 MGSep 6, 202699.745%Superseded
RGX-26-RGNX-644100 MGSep 5, 202699.769%Superseded
RGX-26-RGNX-64550 MGSep 4, 202699.707%Superseded
RGX-26-RGNX-744100 MGSep 2, 202699.669%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →